DipCatcherDipCatcher by KAWUMS
Market
AAL.L3,913.00 p+1.3%AAPL$332.41+0.3%ACN$189.64-1.9%ADA$0.1960+0.3%ADBE$250.50-2.8%ADS.DE€144.70+2.0%AIR.DE€196.74+0.9%ALGO$0.0896+0.9%ALV.DE€449.20+1.0%AMD$512.50+1.6%AMZN$245.96-1.0%ANTO.L3,594.00 p+2.7%ATOM$1.52+0.2%AUTO.L499.60 p+0.9%AV.L714.60 p+0.4%AVAX$7.53+3.5%AVGO$339.51+0.1%AXP$312.43-3.7%AZN.L12,136.00 p+0.2%BA.L2,029.00 p+1.1%BAC$57.90-2.7%BARC.L475.43 p+1.1%BAS.DE€52.13+0.6%BATS.L4,196.00 p-0.6%BAYN.DE€48.98+0.6%BCH$220.51+1.6%BEI.DE€74.68+0.2%BMW.DE€62.40-0.7%BNB$723.61+1.6%BNZL.L2,596.00 p+0.2%BP.L565.75 p-2.5%BRK-B$519.80+0.6%BT-A.L205.80 p+1.0%BTC$76,267.52+0.9%C$132.95-2.4%CAT$782.72-0.1%CBK.DE€41.61-2.0%CCH.L4,604.00 p-0.0%CON.DE€69.86+1.9%COST$893.74-0.8%CPG.L31.09 p-1.0%CRDA.L3,148.00 p-0.2%CRM$250.54-2.0%CSCO$107.74-2.1%CVX$211.54-2.9%DB1.DE€277.60+0.1%DBK.DE€33.63+0.9%DGE.L1,620.25 p+0.7%DHER.DE€36.70-0.1%DHL.DE€55.76-0.1%DIS$106.99+0.5%DOGE$0.0809+1.0%DOT$1.01+7.0%DTE.DE€28.84-0.2%ENT.L499.80 p+0.3%EOAN.DE€17.60+1.2%ETC$7.40+2.9%ETH$2,433.29+1.4%EVT.DE€2.81+0.1%EXPN.L2,784.00 p-0.6%FME.DE€39.86+0.2%FRE.DE€46.06+1.5%G24.DE€75.00+0.5%GFT.DE€26.25-1.1%GLEN.L570.90 p-0.9%GOOGL$342.87-0.6%GS$937.98-4.0%GSK.L1,865.50 p+0.6%GXI.DE€27.66-0.5%HD$302.47-1.0%HEI.DE€150.90+1.2%HEN3.DE€73.80+1.3%HNR1.DE€255.80+0.2%HON$207.66+2.1%HSBA.L1,511.50 p+0.5%IBM$237.49-4.4%IFX.DE€55.00+1.2%III.L2,668.00 p+2.7%IMB.L2,490.00 p-1.0%INTC$101.05+4.0%JMAT.L2,286.00 p+0.4%JNJ$267.28+0.0%JPM$348.92-1.0%KGX.DE€41.61+0.5%LAND.L636.00 p+1.8%LGEN.L300.75 p+2.2%LHA.DE€7.63+1.1%LINK$11.10+1.9%LLOY.L111.25 p+2.2%LLY$1,137.82+0.2%LOW$194.10-0.3%LSEG.L8,150.00 p-0.6%LTC$51.98+1.4%LXS.DE€13.52-0.9%MA$567.75-1.0%MBG.DE€45.50-2.3%MDT$92.60-1.2%META$673.31+0.5%MNG.L335.40 p+0.6%MS$202.42-1.9%MSFT$490.30-1.4%MTX.DE€339.40+1.8%MUV2.DE€511.60-0.2%NDA.DE€164.60+0.5%NDX1.DE€39.18+1.2%NEE$80.37-0.9%NFLX$76.41-1.9%NG.L1,136.00 p+2.3%NOW$139.82-1.5%NVDA$213.90+0.8%OCDO.L212.60 p+2.8%ORCL$143.16+2.0%PAH3.DE€28.73-1.8%PEP$134.34-0.9%PG$147.02+0.2%PM$191.71-1.2%PRU.L979.50 p+0.6%PSN.L1,163.00 p+5.9%PUM.DE€22.36+2.5%QCOM$184.84-1.6%QIA.DE€37.27+0.2%REL.L2,530.00 p-0.2%RIO.L7,202.00 p+0.8%RKT.L5,064.00 p-0.0%RMV.L501.40 p+0.7%RR.L1,440.60 p+1.4%RWE.DE€59.90+2.8%SAP.DE€186.20-0.5%SAX.DE€36.56-0.3%SBRY.L334.50 p-0.7%SBUX$97.34+0.8%SDF.DE€16.71+1.6%SGE.L1,011.50 p+0.4%SGRO.L942.00 p+0.7%SHEL.L3,577.00 p-2.1%SHIB$0.0000-0.2%SHL.DE€38.36-1.3%SIE.DE€260.50+0.7%SOL$99.42+2.6%SSE.L2,405.00 p+3.1%STAN.L2,287.00 p+0.9%SY1.DE€91.46+2.3%T$25.86-3.2%TKA.DE€15.44+1.9%TRX$0.3355+0.8%TSCO.L476.20 p-0.7%TSLA$358.08+0.4%TXN$260.67-1.0%ULVR.L4,640.00 p-0.0%UNH$375.26-0.2%UNP$280.92-1.1%UPS$98.77-3.5%V$370.93-1.2%VNA.DE€17.89-0.7%VOD.L130.92 p-0.2%VOW3.DE€79.20-2.2%WEIR.L2,634.00 p+1.4%WMT$107.50-0.5%WPP.L381.20 p-0.8%XLM$0.1824+3.5%XOM$163.32-3.5%XRP$1.30+0.9%ZAL.DE€21.48-1.2%
Dips
HON-17.1%Buy VNA.DE-16.9%Buy OCDO.L-22.3%Watch FME.DE-7.8%Watch BA.L-12.1%Watch ADS.DE-15.5%Watch AUTO.L-10.6%Watch G24.DE-8.6%Watch GOOGL-10.8%Watch LLY-12.0%Watch

JNJ

NYSE

Johnson & Johnson

Healthcare · Drug Manufacturers - General

$267.28
+0.0% today · 5 h ago

Price

+14.2% · 3 months
1m3m6m
$239.56$252.98$266.4016/06/202631/07/202616/09/2026
High $278.43 · 03/09/2026Low $227.27 · 18/06/2026

Verdict

signal 51 min ago
HOLD-4.9% below 30-day high

No buyable dip: 4.9% below its 30-day high. Nothing to do here.

Sign in to watch

Catalysts

1 h ago
News, last 10 days
positive +0.2410 articles
Next earnings
13/10/2026 · in 26 days
Last report
15/07/2026 +1.6% vs estimate

Trade levels

Free account · 3 tickers a day

Why the engine says so

Free account · 3 tickers a day

History for this ticker

Free account · 3 tickers a day

Watch and alert

Free account · 3 tickers a day

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Headquarters:
New Brunswick, United States
52-week range:
$173.33 – $281.07
Website:
jnj.com

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search